1. Academic Validation
  2. Seeded aggregation of TDP-43 induces its loss of function and reveals early pathological signatures

Seeded aggregation of TDP-43 induces its loss of function and reveals early pathological signatures

  • Neuron. 2025 May 21;113(10):1614-1628.e11. doi: 10.1016/j.neuron.2025.03.008.
Carlo Scialò 1 Weijia Zhong 1 Somanath Jagannath 1 Oscar Wilkins 2 Davide Caredio 3 Marian Hruska-Plochan 1 Flavio Lurati 1 Martina Peter 1 Elena De Cecco 3 Luigi Celauro 4 Adriano Aguzzi 3 Giuseppe Legname 4 Pietro Fratta 2 Magdalini Polymenidou 5
Affiliations

Affiliations

  • 1 Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
  • 2 UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK; The Francis Crick Institute, London, UK.
  • 3 Institute of Neuropathology, University of Zurich, Zurich, Switzerland.
  • 4 Laboratory of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy.
  • 5 Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland. Electronic address: magdalini.polymenidou@uzh.ch.
Abstract

Neurodegeneration in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) results from both gain of toxicity and loss of normal function of the RNA-binding protein TDP-43, but their mechanistic connection remains unclear. Increasing evidence suggests that TDP-43 aggregates act as self-templating seeds, propagating pathology through the central nervous system via a prion-like cascade. We developed a robust TDP-43-seeding platform for quantitative assessment of TDP-43 aggregate uptake, cell-to-cell spreading, and loss of function within living cells, while they progress toward pathology. We show that both patient-derived and recombinant TDP-43 pathological aggregates were abundantly internalized by human neuron-like cells, efficiently recruited endogenous TDP-43, and formed cytoplasmic inclusions reminiscent of ALS/FTD pathology. Combining a fluorescent reporter of TDP-43 function with RNA Sequencing and proteomics, we demonstrated aberrant cryptic splicing and a loss-of-function profile resulting from TDP-43-templated aggregation. Our data highlight known and novel pathological signatures in the context of seed-induced TDP-43 loss of function.

Keywords

ALS/FTD; RNA-binding proteins; TDP-43; aggregation; cryptic splicing; loss of function; low-complexity domain; neurodegeneration; seeding; spreading.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-50767
    99.94%, CDK4/6 Inhibitor
    CDK